2012
DOI: 10.1016/j.jaci.2011.10.045
|View full text |Cite
|
Sign up to set email alerts
|

Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

12
141
1
4

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 153 publications
(158 citation statements)
references
References 26 publications
12
141
1
4
Order By: Relevance
“…On the contrary, the pollen quantity significantly varied with a gradient from North to South with the exception of Liguria, where very low values were observed. The present molecular outcomes are substantially consistent with previous surveys conducted in Italy, that showed the preeminence of IgE reactivity to Phl p 1 and Phl p 5 (11)(12)(13). In particular, Phl p 1 appears as the most important species-specific Phl p allergen.…”
Section: Central Italy Southern Italysupporting
confidence: 91%
“…On the contrary, the pollen quantity significantly varied with a gradient from North to South with the exception of Liguria, where very low values were observed. The present molecular outcomes are substantially consistent with previous surveys conducted in Italy, that showed the preeminence of IgE reactivity to Phl p 1 and Phl p 5 (11)(12)(13). In particular, Phl p 1 appears as the most important species-specific Phl p allergen.…”
Section: Central Italy Southern Italysupporting
confidence: 91%
“…A growing spectrum of molecules, representing single allergens of clinical relevance have been identified, characterized and produced for commercial in vitro assays. This 'component resolved diagnosis' (CRD) thus allows a detailed molecular profiling of the polyclonal IgE repertoire of the allergic patient [8].…”
mentioning
confidence: 99%
“…It remains firm that molecular allergy diagnosis, especially with multiplexed instruments, remains a third-line approach, to be used only in patients with a complex polysensitization profile, and when the standard diagnostics are insufficient to choose the appropriate allergen(s) for AIT [12]. On the other hand, a "tailored" AIT, using only the genuine sensitizers seems difficult to realize, since there are too many different sensitization profiles [39][40][41], and so far, commercial extracts (that are less expensive) perform as well as purified/recombinant molecules for AIT [42,43]. Allergen specific immunotherapy (AIT) is a well-documented effective treatment for respiratory and hymenoptera venom allergy [44][45][46][47][48][49].…”
Section: Allergen Immunotherapy Molecular Based Diagnostics and Pmmentioning
confidence: 99%